X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home IPR Data Management

Empowering Pharma 4.0 Data Management with PAT Software

Content Team by Content Team
26th July 2023
in IPR Data Management, News
Empowering Pharma 4.0 Data Management with PAT Software

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Glass bottles are being filled with medicines, including antibiotics and vaccines, through an automatic liquid dispenser on a production line. This process is crucial for biopharmaceutical companies to remain competitive and embrace digitalization. A Process Analytical Technology (PAT) knowledge management platform plays a vital role in supporting these companies’ digital transformation.

Data plays a leading role in driving manufacturers’ competitiveness and optimizing production. Sophisticated analyzers like Raman and near-infrared (NIR) spectrometers are now commonly used, allowing real-time measurement of Critical Quality Attributes (CQAs) that were previously only accessible offline with delays. By leveraging data from various sources, companies gain a deep understanding of their processes, performance drivers, and how to enhance productivity, efficiency, and quality. This knowledge empowers them to make proactive decisions and implement integrated, intelligent systems, potentially automating tasks.

As biopharmaceutical companies deal with vast real-time data from diverse analyzers, it becomes crucial to plan how to optimize and utilize this information. Creating a solid framework to handle data and control processes based on quality goals is essential for succeeding in Industry 4.0 and digitalization.

A PAT knowledge management system is an invaluable tool in this regard. It aligns well with the principles of Industry 4.0, as it focuses on designing, analyzing, and controlling manufacturing processes by measuring CQAs to effectively manage CPPs for optimal outcomes.

With advancements in sensing, detection systems, and digital technology, future-oriented PAT knowledge management systems can leverage opportunities from Industry 4.0. This includes accurate determination of how CPPs influence CQAs through predictive models, potentially utilizing artificial intelligence. These advanced systems also offer Cloud connectivity and integration with various devices for highly mechanized processes and quality-centric control.

A state-of-the-art PAT knowledge management platform goes beyond supporting quality control and assurance. It becomes a central hub for data-driven operations, providing high visibility and enabling flexible, responsive, and efficient processes. This digitalization extends from R&D labs to large-scale manufacturing facilities.

PAT knowledge management solutions are becoming essential elements of industrial automation projects, much like controllers, robots, MES, ERP, and HMIs. An example of such a solution is synTQ, a market-leading software used by numerous pharmaceutical companies worldwide. synTQ enhances competitiveness by enabling scalable Big Data analytics for innovative IIoT applications, leading to increased transparency, efficiency, and responsiveness in labs and manufacturing floors.

Previous Post

Employee - Driven Digital Transformation In Life Science

Next Post

Rapid Growth Predicted In The Small Molecule API Market

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

Rapid Growth Predicted In The Small Molecule API Market

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In